These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24918262)

  • 1. Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
    Grandi G; Piacenti I; Volpe A; Cagnacci A
    Gynecol Endocrinol; 2014 Sep; 30(9):676-80. PubMed ID: 24918262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
    Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
    Contraception; 2009 Feb; 79(2):111-6. PubMed ID: 19135567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
    Kangasniemi MH; Haverinen A; Luiro K; Hiltunen JK; Komsi EK; Arffman RK; Heikinheimo O; Tapanainen JS; Piltonen TT
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
    De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
    Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
    J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dienogest-containing oral contraceptives on lipid metabolism.
    Wiegratz I; Lee JH; Kutschera E; Bauer HH; von Hayn C; Moore C; Mellinger U; Winkler UH; Gross W; Kuhl H
    Contraception; 2002 Mar; 65(3):223-9. PubMed ID: 11929644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W; Mellinger U; Parke S; Serrani M
    Clin Drug Investig; 2011; 31(8):573-584. PubMed ID: 21721593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic impact of combined hormonal contraceptives containing estradiol.
    Grandi G; Napolitano A; Cagnacci A
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):779-87. PubMed ID: 27187588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
    Uras R; Orrù M; Pani F; Marotto MF; Pilloni M; Guerriero S; Etzi R; Zedda P; Sorge R; Lello S; Melis GB; Paoletti AM
    Contraception; 2010 Aug; 82(2):131-8. PubMed ID: 20654753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethinyl estradiol vs estradiol valerate in combined oral contraceptives - Effect on glucose tolerance: A randomized, controlled clinical trial.
    Haverinen A; Kangasniemi M; Luiro K; Piltonen T; Heikinheimo O; Tapanainen JS
    Contraception; 2021 Jan; 103(1):53-59. PubMed ID: 33098852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.